COTA and MedStar Health Partner To Drive Scientific Research and Expedite Delivery of Innovative Cancer Treatments
MedStar Health — the largest healthcare provider in the Maryland and Washington, D.C., region — will leverage COTA’s real-world data expertise to deliver more precise care for cancer patients
COTA, Inc., an oncology real-world data and analytics company, announced a new research partnership with MedStar Health. COTA will support MedStar Health in its use of real-world data to accelerate scientific discovery and improve patient care.
MedStar Health is the largest healthcare provider in the Maryland and Washington, D.C., region. Its cancer team — including MedStar Health Cancer Network and the MedStar Georgetown Cancer Institute — provides care to patients across 10 sites. The Institute’s academic cancer partner — Georgetown Lombardi Comprehensive Cancer Center — is one of only 51 comprehensive cancer centers in the nation to receive this designation by the National Cancer Institute.
“Our partnership with COTA will support our ongoing efforts to leverage deep clinical data to power research that will improve outcomes for cancer patients,” said Neil J. Weissman, MD, FACC, FASE, president of MedStar Health Research Institute and chief scientific officer for MedStar Health. “As a leader in oncology real-world data, we are excited to work with COTA to drive innovative research that will change how cancer is studied and treated.”
“Collecting and understanding data is becoming increasingly important to how we select cancer treatments for individuals,” says Louis M. Weiner, MD, director of the Georgetown Lombardi Comprehensive Cancer Center and the MedStar Georgetown Cancer Institute. “The Institute’s research collaboration with COTA will help accelerate advances and enhance our goal of providing our patients with tomorrow’s cancer treatments, today.”
COTA provides comprehensive oncology real-world data abstraction, curation, and analytics capabilities to leading healthcare provider organizations and life sciences companies that are caring and developing treatments for patients living with a wide range of cancers. The company uniquely combines oncology expertise with technology-enabled data abstraction techniques to curate meaningful, longitudinal, and de-identified datasets.
“At COTA we serve as a critical bridge between healthcare providers and the researchers who can accelerate clinical development to make life-saving treatments available to patients faster,” said Mike Doyle, CEO of COTA. “We are proud to collaborate with MedStar Health, a well-respected leader in oncology, to advance scientific discovery with representative and diverse real-world data.”